| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |